Clinical, biochemical, and immunohistochemical features of necrobiotic xanthogranulomatosis

Journal of Clinical Pathology

Volumn 56, Issue 1, 2003, Pages 64-68

  Jeziorska, M ^a   Hassan, A ^a   Mackness, M I ^a   Woolley, D E ^a   Tullo, A B ^a   Lucas, G S ^a   Durrington, P N ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CELL MARKER; GLYCINE CLEAVAGE SYSTEM; IMMUNOGLOBULIN G; PROTEIN A; PROTEIN S 100; SEPHAROSE;

AGED; ANAMNESIS; ARTICLE; ATHEROSCLEROSIS; CASE REPORT; CELL ACTIVATION; CHROMATOGRAPHY; CLINICAL FEATURE; COLLAGEN DEGRADATION; FEMALE; FOAM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MACROPHAGE; MAST CELL; MONOCYTE; NECROBIOTIC DISORDER; NECROSIS; PARAPROTEINEMIA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SKIN DEFECT; XANTHOGRANULOMA;

AGED; FEMALE; GRANULOMA; HUMANS; MACROPHAGES; MIDDLE AGED; MONOCYTES; NECROBIOTIC DISORDERS; PARAPROTEINEMIAS; XANTHOMATOSIS;

EID: 0037245675     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.1.64     Document Type: Article

References (25)

1. Roberts-Thompson PJ, Venables GS, Onitiri AC, et al. Polygenic 1gA myeloma, hyperlipidaemia and xanthomatosis: a further case and review. Postgrad Med J 1975;51:44-52.
2. Kossard S, Winkelmann RK. Necrobiotic xanthogranuloma. Australas J Dermatol 1980;21:85-8.
3. Mehregan DA, Winkelmann RK. Necrobiotic granuloma. Arch Dermatol 1992;128:94-100.
4. Rose GE, Patel BC, Garner A, et al. Orbital xanthogranuloma in adults. Br J Ophthalmol 1991;75:680-4.
5. Cornblath WT, Dotan SA, Trobe JD, et al. Varied clinical spectrum of necrobiotic xanthogranuloma. Ophthalmology 1992;99:103-7.
6. Winkelmann RK, Litzow MR, Umbert IJ, et al. Giant cell granulomatous pulmonary and myocardial lesions in necrobiotic xanthogranuloma with paraproteinemia. Mayo Clin Proc 1997;72:1028-33.
7. Matsuura F, Yamashita S, Hirano K, et al. Activation of monocytes in viva causes intracellular accumulation of lipoprotein-derived lipids and marked hypocholesterolaemia - a possible pathogenesis of necrobiotic xanthogranuloma. Atherosclerosis 1999;142:355-65.
8. Stone MC, Thorpe JM. A new technique for the investigation of the low density lipoproteins in health and disease. Clin Chim Acta 1966;14:812-30.
9. Arrol S, Mackness MI, Laing I, et al. Lipoprotein secretion by the human hepatoma cell line Hep G2: differential rates of accumulation of apolipoprotein B and lipoprotein lipids in tissue culture media in response to albumin, glucose and oleate. Biochim Biophys Acta 1991;1086:72-80.
10. Feingold KR, Castro GR, Ishikawa Y, et al. Cutaneous xanthoma in association with paraproteinaemia. J Clin Invest 1989;83:796-802.
11. Mackness B, Hunt R, Mackness MI, et al. Increased immunolocalization of paraoxonase, clusterin and apolipoprotein Al in the human artery wall with progression of atherosclerosis. Arterioscler Thromb Vasc Biol 1997;17:1233-38.
12. Ylä-Herttuala S, Palinski W, Butler SW, et al. Rabbit and human atherosclerotic lesions contain IgG that recognises epitopes of oxidized LDL. Arterioscler Thromb 1994;14:32-40.
13. Takahashi W, Naito M. Lipid storage disease: part 1. Ultrastructure of xanthoma cells in various diseases. Acta Pathol Jpn 1983;33:959-77.
14. Lendon C, Davies MJ, Born G, et al. Atherosclerotic plaque caps are locally weakened when macrophage density is increased. Atherosclerosis 1991;87:87-90.
15. Moreno PR, Falk E, Palacios IF, et al. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 1994;90:775-8.
16. Galis ZS, Sukhova GK, Lark MW, et al. Increased expression of matrix-metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493-503.
17. Lees M, Taylor DJ, Woolley DE. Mast cell proteinases activate precursor forms of collagenase and stromolysin, but not of gelatinase A and B. Eur J Biochem 1994;223:171-7.
18. Huang Y, Fleming AJ, Wu S, et al. Fc-γ receptor cross-linking by immune complexes induces matrix metalloproteinase-1 in U937 cells via nitrogen-activated protein kinase. Arterioscler Thromb Vasc Biol 2000;20:2533-8.
19. Klimov AN, Denisenko AD, Popov AN, et al. Lipoprotein-antibody immune complexes. Their catabolism and role in foam cell formation. Atherosclerosis 1985;58:1-15.
20. Johnston JD, Lumb PJ, Wierzbicki AS. Hyperlipidaemia in association with benign paraproteinaemia. Ann Clin Biochem 1997;34:697-9.
21. Giry C, Giroux L-M, Roy M, et al. Characterization of inherited scavenger receptor overexpression and abnormal macrophage phenotype in a normolipidemic subject with planar xanthomas. J Lipid Res 1996;37:1422-35.
22. Kovanen PT. Role of mast cells in atherosclerosis. In: Marone G, ed. Human basophils and mast cells: clinical aspects. Chemical Immunology 1995, Vol. 62. Basel: Karger, 1995:132-70.
23. Jeziorska M, McCollum C, Woolley DE. Mast cell distribution, activation and phenotype in atherosclerotic lesions of human carotid arteries. J Pathol 1997;182:115-22.
24. Matthew NT, Meyer JS, Achori AN, et al. Hyperlipidaemic neuropathy and dementia. Eur Neurol 1976;14:370-82.
25. Turnberg LA, Mahoney MP, Gleeson MH, et al. Plasmapheresis and plasma exchange in the treatment of hyperlipaemia and xanthomatous neuropathy in patients with primary biliary cirrhosis. Gut 1972;13:976-81.